Search Results

Source: Journal of Psychoactive Drugs
Resulting in 2 citations.
1. Lo, Celia C.
Cheng, Tyrone C.
Race, Employment Disadvantages, and Heavy Drinking: A Multilevel Model
Journal of Psychoactive Drugs 47,3 (2015): 221-229.
Also: http://www.tandfonline.com/doi/full/10.1080/02791072.2015.1047541
Cohort(s): NLSY79
Publisher: Taylor & Francis Group
Keyword(s): Alcohol Use; Employment; Modeling, Multilevel; Racial Differences

Permission to reprint the abstract has not been received from the publisher.

We intended to determine (1) whether stress from employment disadvantages led to increased frequency of heavy drinking and (2) whether race had a role in the relationship between such disadvantages and heavy drinking. Study data came from the National Longitudinal Survey of Youth, a prospective study that has followed a representative sample of youth since 1979. Our study employed data from 11 particular years, during which the survey included items measuring respondents' heavy drinking. Our final sample numbered 10,171 respondents, which generated 75,394 person-waves for data analysis. Both of our hypotheses were supported by results from multilevel mixed-effects linear regression capturing the time-varying nature of three employment disadvantages and of the heavy-drinking outcome. Results show that more-frequent heavy drinking was associated with employment disadvantages, and that disadvantages' effects on drinking were stronger for Blacks and Hispanics than for Whites. That worsening employment disadvantages have worse effects on minority groups' heavy drinking (compared to Whites) probably contributes to the racial health disparities in our nation. Policies and programs addressing such disparities are especially important during economic downturns.
Bibliography Citation
Lo, Celia C. and Tyrone C. Cheng. "Race, Employment Disadvantages, and Heavy Drinking: A Multilevel Model." Journal of Psychoactive Drugs 47,3 (2015): 221-229.
2. Silver, Ian A.
Kelsay, James D.
Lonergan, Holly
Illegal Drug Use, Depressive Symptoms, and General Health: Exploring Co-occurrence across 11 Years in a National Sample
Journal of Psychoactive Drugs published online (23 March 2022): DOI: 10.1080/02791072.2022.2053003.
Also: https://www.tandfonline.com/doi/full/10.1080/02791072.2022.2053003
Cohort(s): NLSY97
Publisher: Taylor & Francis Group
Keyword(s): Depression (see also CESD); Drug Use; Health/Health Status/SF-12 Scale

Permission to reprint the abstract has not been received from the publisher.

The co-occurrence of illegal drug use, symptoms of depression, and a lower perception of general health among adolescents continues to be of substantive interest for researchers and the general public alike. Research on this topic, however, remains relatively stagnant, focusing on narrow developmental periods and each association independently, with limited consideration for the existence of a nexus between the three constructs as individuals age. Considering these limitations, the current study examines the longitudinal progression, from adolescence to early adulthood, of illegal drug use, symptoms of depression, and a lower perception of general health. The National Longitudinal Survey of Youth 1997 (NLSY97; N = 8,984), measures over an eleven-year data collection period, and between-and within-individual analytical strategies were used to evaluate the nexus between the constructs. The findings suggested that illegal drug use, depressive symptoms, and general health at previous time periods directly and indirectly predicted illegal drug use, depressive symptoms, and general health at subsequent time periods. Moreover, the within-individual change in illegal drug use was associated with the change in depressive symptoms, and the change in depressive symptoms was associated with the change in general health. Practitioners should consider this co-occurrence when treating symptoms related to illegal drug use, symptoms of depression, and physical health.
Bibliography Citation
Silver, Ian A., James D. Kelsay and Holly Lonergan. "Illegal Drug Use, Depressive Symptoms, and General Health: Exploring Co-occurrence across 11 Years in a National Sample." Journal of Psychoactive Drugs published online (23 March 2022): DOI: 10.1080/02791072.2022.2053003.